Gilead's Remdesivir First Drug to Win FDA Approval for Coronavirus
It had previously received Emergency Use Authorization to treat the disease.
Full Article
Gilead's Remdesivir First Drug to Win FDA Approval for Coronavirus
Motley Fool
0 shares
1 views
You might like
Related news coverage
NA Proactive news snapshot: ElectraMeccanica Vehicles, Willow Biosciences, DRDGOLD Limited, Aurania Resources UPDATE ...
Proactive Investors
ElectraMeccanica Vehicles Corp (NASDAQ:SOLO) announced Thursday that an initial shipment of production SOLO electric vehicles have..
-
NA Proactive news snapshot: DGTL Holdings, First Cobalt, American Resources, Progressive Planet, Silver Range Resources, African Gold Group UPDATE...
Proactive Investors
-
Gilead Sciences says remdesivir plays important role for COVID-19 patients treatment
Proactive Investors
-
BetterLife Pharma to conduct telemedicine coronavirus trials of AP-003 to ease access for patients
Proactive Investors
-
NA Proactive news snapshot: Revive Therapeutics, KULR Technology, Lexaria Bioscience, TRACON Pharmaceuticals UPDATE …
Proactive Investors
Advertisement
More coverage
NA Proactive news snapshot: KWESST Micro Systems, WeedMD, Bragg Gaming Group, MGX Minerals, Phunware, Nextleaf Solutions, Candelaria Mining UPDATE…
Proactive Investors
KWESST Micro Systems Inc. (CVE:KWE) said it has extended its option to acquire a proprietary non-lethal munitions technology system..
-
NA Proactive news snapshot: Esports Entertainment Group, CytoDyn, ImagineAR, GlobeX Data …
Proactive Investors
-
Biotech Stocks Facing FDA Decision In November 2020
RTTNews
-
US stocks end mixed as investors weigh coronavirus stimulus package negotiations
Proactive Investors
-
The Latest: Pine Ridge Reservation locks down for a week
SeattlePI.com